Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

California Report Finds Dermatological Agents Rank Highest in Drug Spend

According to claim data from the CWCI, in 2024 dermatological agents made up 12.6% of prescriptions and 18.9% of drug spend.
Read More →
January 20, 2025

Maryland Proposes Pharmacy Fee Schedule with Actual Acquisition Cost

If enacted, this fee schedule would replace the current usual and customary charges, going into effect October 1, 2025.
Read More →
January 20, 2025

WCRI Publishes New Report on Heat-Related Illnesses

Approximately 210 out of every 100,000 claims were for heat-related illness, but the rate increases for inexperienced workers and outdoor workers.
Read More →
January 13, 2025

Virginia Proposes Longer and Expanded Benefits for PTSD Among First Responders

Three separate bills were introduced, two which increase maximum duration of benefits, while one would expand benefits to dispatchers.
Read More →
January 13, 2025

New York Introduces Psilocybin Therapy Bill

Senate Bill 495 seeks to legalize medical psilocybin under strict conditions with state-regulated training, research, reporting, and more.
Read More →
January 13, 2025

New York Bill Seeks to Limit Recently Enacted Mental Injury Presumption

A bill passed in December 2024 created a mental injury presumption for all workers, but now regulators seek to limit that law with a new bill.
Read More →
January 13, 2025

Maine Considers Permanent Extension to PTSD Legislation for First Responders

House Bill 82 would indefinitely extend presumptions that are set to expire October 1st.
Read More →
January 13, 2025

Florida Panel to Issue Policy Recommendation for Fee Schedule

The three-member panel will recommend to legislators that the DWC be allowed to update fee schedules without legislative approval.
Read More →
January 13, 2025

Connecticut Could Expand List of Qualifying Incidents for PTSD Presumption

Senate Bill 228 would allow for PTSD coverage in first responders outside of incidents involving death, loss of a body part, or loss of body function.
Read More →
January 13, 2025
1 … 32 33 34 35 36 … 45

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Connecticut Enacts Major COVID-19 Presumption

Beyond first responders and healthcare workers, essential workers including grocery store workers are now covered by workers’ comp.
Read More

Department of Labor Audit: COVID-19’s Impact on Comp

A new report on how federal workers’ comp claims have been impacted.
Read More

Virginia Adopts Workplace Safety Standards for COVID-19

Standards are in place for PPE, social distancing, testing procedures, and more.
Read More

FDA Approves Hulio for Rheumatoid Arthritis and More

Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.
Read More

States Pass COVID-19 Liability Limitations

Arkansas and Louisiana enacted policies to protect businesses from civil liability stemming from COVID-19 exposure.
Read More

WCRI Reports on Interstate Variation Trends in Drug Payments

Data from 28 states years found that NSAIDs and dermatological agents are seeing growth in spending.
Read More
1 … 32 33 34 35 36 … 49
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle